Sort
48,018 grants matching “immunotherapy”
P5 - P-53-Based Vaccine for Small Cell Lung Cancer
$400,000Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2012 · CA
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
$400,000Weiguo Cui · Northwestern University At Chicago · R01 · FY2023 · AI
Liquid Immunogenic Fiducial Eluter (LIFE) for Cervical Cancer Treatment
$400,000Adam Shilling · Nanocan Therapeutics Corporation · R41 · FY2022 · CA
CANCER CENTER SUPPORT GRANT
$400,000University Of Colorado Denver · P30 · FY2001 · CA
Regulation and function of nonlymphoid organ CD103 dendritic cells
$400,000Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · AI
Evaluation of lead FANA oligos targeting FOXP3, with and without anti-PD-1 mAb, as an approach for cancer immunotherapy
$400,000Veenu Aishwarya · Aum Lifetech, Inc. · R43 · FY2022 · CA
Activating TFEB to enhance the efficacy of immunotherapy for triple negative breast cancer
$400,000Daping Fan · Promilead, Llc · R41 · FY2025 · CA
Point-of-care autologous CAR-T cell manufacturing
$400,000Yu-Tsueng Liu · Aerocytek, Inc. · R43 · FY2025 · CA
Development of a DISE-inducing, short RNA therapeutic to treat ovarian cancer
$400,000Robert Schickel · Nuago Therapeutics Inc · R42 · FY2025 · CA
SBIR Phase II: Clinical-Scale Suspension Bioreactor for Primary Hematopoietic Culture
$400,000Todd A McAdams · Tissue Therapeutics · · FY2000 · TIP
Microsatellite Instability Sequencing via Single-Molecule DNA Re-Reading
$400,000Anna Schibel · Electronic Biosciences, Inc. · R43 · FY2023 · CA
Calcium Dependent Signaling in Airway Epithelial Cells
$400,000Alice S Prince · Columbia University Health Sciences · R01 · FY2015 · HL
A novel and effective immunotherapeutic approach for tumors with a low mutational load and few tumor-infiltrating lymphocytes, such as ovarian cancer
$400,000Jennifer June Sessions · Cynvec, Llc · R44 · FY2020 · CA
Allogeneic cell and gene therapy for neuroendocrine tumors
$400,000Brian G Petrich · Expression Therapeutics · R43 · FY2025 · CA
A novel MICA/B based tumor-centric bispecific antibody that enhances NK cell activity in a hostile tumor microenvironment
$400,000Hemanta Baruah · Aakha Biologics Inc. · R43 · FY2024 · CA
SIRPant Technology for anti-Cancer Immunity
$400,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2021 · CA
Comprehensive Cancer Center Program at Fox Chase
$400,000Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · P30 · FY2021 · CA
Enzymology of Mismatch Repair in Yeast
$400,000Richard D Kolodner · Ludwig Institute For Cancer Res Ltd · R01 · FY2021 · GM
Protective and Pathologic Roles for CD8+ T cells in Leishmaniasis
$400,000Phillip A. Scott · University Of Pennsylvania · R01 · FY2016 · AI
Phase 2 Study of Folfirinox Followed by Ipilimumab/GVAX in Pancreatic Cancer
$400,000Dung T Le · Johns Hopkins University · R01 · FY2015 · FD
Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation
$400,000Siu Kit Lam · Immunophotonics, Inc. · R44 · FY2021 · CA
OSTEOGENIC AND IMMUNOMODULATORY PROPERTIES OF DECIDUOUS TOOTH STEM CELLS
$400,000Songtao Shi · University Of Pennsylvania · R01 · FY2015 · DE
Advancing Next Generation CAR-T cells for Renal Cell Carcinoma
$400,000Premal Patel · Cellinfinity Bio, Inc. · R44 · FY2024 · CA
CAREER: Engineering Therapeutic Immune Responses with Artificial Antigen-Presenting Cells
$400,000Tarek Fahmy · Yale University · · FY2008 · ENG
OSTEOGENIC AND IMMUNOMODULATORY PROPERTIES OF DECIDUOUS TOOTH STEM CELLS
$400,000Songtao Shi · University Of Pennsylvania · R01 · FY2017 · DE